Clinical Trials Directory

Trials / Completed

CompletedNCT00005709

Lipoprotein Metabolism in Hypertensive African-Americans

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
National Heart, Lung, and Blood Institute (NHLBI) · NIH
Sex
Male
Age
100 Years
Healthy volunteers
Not accepted

Summary

To study relationships among lipoprotein metabolism, hypertension, and hyperinsulinemia-insulin resistance in African American males and females. The study was part of a Collaborative Project on Minority Health which investigated the mechanisms by which insulin contributes to cardiovascular disease.

Detailed description

BACKGROUND: The study was part of the initiative "Collaborative Projects (R01s) on Minority Health". The concept for the initiative was developed by the NHLBI staff after the 1993 Report of the Committee on Appropriations, House of Representatives, encouraged the NHLBI to establish minority centers to facilitate the diagnosis and treatment of cardiovascular diseases. The initiative was approved at the September 1992 National Heart, Lung, and Blood Advisory Council and released in October 1992. Julian Marsh was one of three investigators in a collaborative program with Bonita Falkner as Program Coordinator. DESIGN NARRATIVE: In a sub-set of subjects with either high or low plasma insulin levels after a glucose challenge (insulin sensitive or insulin resistant), the investigators determined the fractional and absolute synthesis and catabolic rates of apolipoproteins B and A-I, the dominant lipoproteins of Low Density Lipoprotein (LDL) and High Density Lipoprotein (HDL). They used stable isotopes and multicompartmental kinetic analysis following an oral bolus dose of deuteroleucine. They hypothesized that in hypertensive African Americans with hyperinsulinemia, more of the smaller Very Low Density (VLDL) particles are secreted and converted to LDL. The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Conditions

Timeline

Start date
1993-09-01
Completion
1998-08-01
First posted
2000-05-26
Last updated
2016-05-13

Source: ClinicalTrials.gov record NCT00005709. Inclusion in this directory is not an endorsement.